A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 118.30
GOOG 742.60
MSFT 54.35
FB 104.24
BAC 17.43

Recently Added

TITN 12.57
LGIH 33.26
ENSG 47.57
SWN 9.01
CCP 31.65

Gaining Speed

TITN 12.57
LGIH 33.26
ACHC 69.01
OXY 75.59
FTNT 36.02

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More

Get Alerted When News Hits On This Stock - FREE!